Literature DB >> 23312439

How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?

Mark W Johnson.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23312439     DOI: 10.1016/j.ajo.2012.10.016

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  10 in total

1.  A retrospective study of a single practice use of ocriplasmin in the treatment of vitreomacular traction.

Authors:  Victoria Morrison Knudsen; Igor Kozak
Journal:  Saudi J Ophthalmol       Date:  2014-02-19

2.  The Charles Schepens Lecture: Management Options for Vitreomacular Traction: Use an Individualized Approach.

Authors:  Harry W Flynn; Nidhi Relhan
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

3.  Pneumatic release of focal vitreomacular traction.

Authors:  M G Claus; E Feron; M Veckeneer
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

Review 4.  Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential.

Authors:  Su Jeong Song; William E Smiddy
Journal:  Core Evid       Date:  2014-03-21

5.  Rhegmatogenous retinal detachment following intravitreal ocriplasmin.

Authors:  Haifa A Madi; Richard J Haynes; Diana Depla; Morten D de la Cour; Sarit Lesnik-Oberstein; Mahi M K Muqit; Niall Patton; Nick Price; David H W Steel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-08       Impact factor: 3.117

6.  PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.

Authors:  Clement K Chan; Jason N Crosson; Calvin E Mein; Noha Daher
Journal:  Retina       Date:  2017-10       Impact factor: 4.256

7.  Type VII Collagen Expression in the Human Vitreoretinal Interface, Corpora Amylacea and Inner Retinal Layers.

Authors:  Bart Wullink; Hendri H Pas; Roelofje J Van der Worp; Roel Kuijer; Leonoor I Los
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

8.  Retinal breaks due to intravitreal ocriplasmin.

Authors:  Ruwan A Silva; Darius M Moshfeghi; Theodore Leng
Journal:  Clin Ophthalmol       Date:  2014-08-25

9.  Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance.

Authors:  Mahiul M K Muqit; Robin Hamilton; Jason Ho; Sally Tucker; Helen Buck
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

10.  Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report.

Authors:  Alessandra Rosati; Raffaele Antonio Esposito; Giuseppe Mannino; Gianluca Scuderi
Journal:  Case Rep Ophthalmol       Date:  2018-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.